CY1111763T1 - ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51 - Google Patents

ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51

Info

Publication number
CY1111763T1
CY1111763T1 CY20111100801T CY111100801T CY1111763T1 CY 1111763 T1 CY1111763 T1 CY 1111763T1 CY 20111100801 T CY20111100801 T CY 20111100801T CY 111100801 T CY111100801 T CY 111100801T CY 1111763 T1 CY1111763 T1 CY 1111763T1
Authority
CY
Cyprus
Prior art keywords
protein
antibodies against
recombinant
fragment
antibody
Prior art date
Application number
CY20111100801T
Other languages
English (en)
Inventor
Yoji Ikawa
Shuntaro Ikawa
Masuo Obinata
Original Assignee
Otsuka Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co., Ltd filed Critical Otsuka Pharmaceutical Co., Ltd
Publication of CY1111763T1 publication Critical patent/CY1111763T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Ανασυνδυασμένη πρωτεΐνη p51 που περιλαμβάνει αλληλουχία αμινοξέων της αλληλουχίας αρ. 1 [SEQ ID ΝΟ:1], όπου αυτή η ανασυνδυασμένη πρωτεΐνη p51 εκφράζεται από κύτταρα μετασχηματισμένα με τον φορέα έκφρασης p51, απομονωμένο αντίσωμα ή θραύσμα αυτού που δεσμεύεται ειδικά με αυτήν την πρωτεΐνη p51 και κιτ που περιλαμβάνει αυτό το αντίσωμα ή θραύσμα αυτού.
CY20111100801T 1998-03-27 2011-08-22 ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51 CY1111763T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10046798 1998-03-27
EP07013470A EP1847607B1 (en) 1998-03-27 1999-03-24 Antibodies against the p51 protein

Publications (1)

Publication Number Publication Date
CY1111763T1 true CY1111763T1 (el) 2015-10-07

Family

ID=14274724

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100801T CY1111763T1 (el) 1998-03-27 2011-08-22 ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51

Country Status (13)

Country Link
US (4) US7132276B1 (el)
EP (2) EP1847607B1 (el)
JP (1) JP4336926B2 (el)
CN (1) CN100340665C (el)
AT (2) ATE512162T1 (el)
CA (1) CA2324649C (el)
CY (1) CY1111763T1 (el)
DE (1) DE69936513D1 (el)
DK (1) DK1847607T3 (el)
ES (1) ES2366234T3 (el)
HK (1) HK1034288A1 (el)
PT (1) PT1847607E (el)
WO (1) WO1999050412A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000818A1 (fr) * 1999-06-29 2001-01-04 Nippon Kayaku Kabushiki Kaisha Gene codant le domaine promoteur du gene suppresseur de tumeur p51 et utilisation
EP1728210A2 (en) * 2004-02-27 2006-12-06 Aureon Laboratories, Inc. Methods and systems for predicting occurrence of an event
CN102181570A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定鼠遗传稳定性相关基因的专用引物及其应用
CN102181571A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定猪遗传稳定性相关基因的专用引物及其应用
CN104212879B (zh) * 2013-06-05 2016-09-21 上海派森诺生物科技股份有限公司 一种基于磁珠富集法高通量开发基因组ssr标记的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744455B1 (fr) 1996-02-02 1998-04-24 Sanofi Sa Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
AU7478098A (en) 1997-05-12 1998-12-08 Dana-Farber Cancer Institute Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
US7294459B1 (en) * 1997-10-15 2007-11-13 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
WO1999019357A2 (en) * 1997-10-15 1999-04-22 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
CA2323093A1 (en) 1998-03-18 1999-09-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6476206B1 (en) 1998-03-27 2002-11-05 The Johns Hopkins University p40 protein acts as an oncogene
DE19822985C1 (de) 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie

Also Published As

Publication number Publication date
EP1847607A1 (en) 2007-10-24
WO1999050412A1 (fr) 1999-10-07
CA2324649C (en) 2007-05-15
US20100285499A1 (en) 2010-11-11
US7964367B2 (en) 2011-06-21
ATE366810T1 (de) 2007-08-15
JP4336926B2 (ja) 2009-09-30
DK1847607T3 (da) 2011-07-18
HK1034288A1 (en) 2001-10-19
DE69936513D1 (de) 2007-08-23
US20060115852A1 (en) 2006-06-01
EP1847607B1 (en) 2011-06-08
ES2366234T3 (es) 2011-10-18
EP1065270B1 (en) 2007-07-11
PT1847607E (pt) 2011-08-25
ATE512162T1 (de) 2011-06-15
US7553933B2 (en) 2009-06-30
EP1065270A1 (en) 2001-01-03
CN100340665C (zh) 2007-10-03
US7754857B2 (en) 2010-07-13
CN1295615A (zh) 2001-05-16
EP1065270A4 (en) 2004-12-29
CA2324649A1 (en) 1999-10-07
US20090142783A1 (en) 2009-06-04
US7132276B1 (en) 2006-11-07

Similar Documents

Publication Publication Date Title
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
KR970707153A (ko) 카텝신 02 프로테아제(cathepsin 02 protease)
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
WO2002002627A3 (en) Interferon-like protein zcyto21
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
AU1444699A (en) Single-chain polypeptides comprising troponin i and troponin
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
EP0293827A3 (en) Assay for leishmaniasis
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
EP0723014A3 (en) cDNA of DOCK180 gene and DOCK180 protein
DE69831584T2 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
ZA91699B (en) Antibodies specifically recognizing somatotropin binding protein
DK0959895T3 (da) Peptider modtagelige over for antistoffer mod peptidconsensussekvenser af C24-CFA/I proteinfamilien
NZ606260A (en) Novel polypeptides involved in immune response
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.